This HTML5 document contains 95 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
dcthttp://purl.org/dc/terms/
dbohttp://dbpedia.org/ontology/
foafhttp://xmlns.com/foaf/0.1/
n14https://global.dbpedia.org/id/
dbthttp://dbpedia.org/resource/Template:
rdfshttp://www.w3.org/2000/01/rdf-schema#
freebasehttp://rdf.freebase.com/ns/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
wikipedia-enhttp://en.wikipedia.org/wiki/
provhttp://www.w3.org/ns/prov#
dbphttp://dbpedia.org/property/
dbchttp://dbpedia.org/resource/Category:
xsdhhttp://www.w3.org/2001/XMLSchema#
wikidatahttp://www.wikidata.org/entity/
dbrhttp://dbpedia.org/resource/

Statements

Subject Item
dbr:Temporary_class_drug
rdfs:label
Temporary class drug
rdfs:comment
A temporary class drug is a relatively new status for controlled drugs, which has been adopted in some jurisdictions, notably New Zealand and the United Kingdom, to attempt to bring newly synthesised designer drugs under legal control. The controlled drug legislation in these jurisdictions requires drug scheduling decisions to follow an evidence-based process, where the harms of the drug are assessed and reviewed so that an appropriate legal status can be assigned. Since many designer drugs sold in recent years have had little or no published research that could help inform such a decision, they have been widely sold as "legal highs", often for months, before sufficient evidence accumulates to justify placing them on the controlled drug schedules.
dct:subject
dbc:Drug_control_law
dbo:wikiPageID
35344421
dbo:wikiPageRevisionID
1080829219
dbo:wikiPageWikiLink
dbr:AM-694 dbr:Kava dbr:4-Cl-AM-2201 dbr:CUMYL-PICA dbr:EAM-2201 dbr:CUMYL-PINACA dbr:CUMYL-THPINACA dbr:4-Methylmethylphenidate dbr:AM-1248 dbr:Secretary_of_State_for_the_Home_Department dbr:XLR-11_(drug) dbr:RCS-4 dbr:Ethylnaphthidate dbr:AM-2201 dbr:MAM-2201 dbr:NNE1 dbr:Methylnaphthidate dbr:Isopropylphenidate dbr:JWH-018 dbr:JWH-019 dbr:QUCHIC dbr:JWH-073 dbr:JWH-081 dbr:Propylphenidate dbr:6-APB dbr:6-APDB dbr:Dissociative dbr:New_Zealand dbr:JWH-122 dbr:AKB48_(drug) dbr:Hordenine dbr:6-MAPDB dbr:5F-PB-22 dbr:NBOMe-2C-B dbr:5-IT dbr:NBOMe-2C-C dbr:Methoxetamine dbr:NBOMe-2C-I dbr:Controlled_drug dbr:JWH-210 dbr:Caffeine dbr:JWH-250 dbr:STS-135_(drug) dbr:JWH-302 dbr:Arylcyclohexylamine dbr:Designer_drug dbr:AB-005 dbc:Drug_control_law dbr:5F-ADBICA dbr:Psychoactive_Substances_Act_2013 dbr:CB-13 dbr:United_Kingdom dbr:PB-22 dbr:Ethylphenidate dbr:JWH-200 dbr:JWH-203 dbr:5F-AKB48 dbr:QUPIC dbr:APICA_(synthetic_cannabinoid_drug) dbr:Methylhexanamine dbr:AB-FUBINACA dbr:Phenyltropane dbr:AM-1220 dbr:CP_55,244 dbr:NBOMe-2C-D dbr:Methiopropamine dbr:5-MAPB dbr:5-MAPDB dbr:6-MAPB dbr:Methylphenidate dbr:Synephrine dbr:Stimulant dbr:Synthetic_cannabis dbr:3,4-Dichloromethylphenidate dbr:6-IT dbr:AM-2232 dbr:AM-2233 dbr:RTI-126 dbr:UR-144 dbr:5-APB dbr:5-APDB
owl:sameAs
wikidata:Q7698976 freebase:m.0j9l4n0 n14:4vhAe
dbp:wikiPageUsesTemplate
dbt:Reflist dbt:Use_dmy_dates
dbo:abstract
A temporary class drug is a relatively new status for controlled drugs, which has been adopted in some jurisdictions, notably New Zealand and the United Kingdom, to attempt to bring newly synthesised designer drugs under legal control. The controlled drug legislation in these jurisdictions requires drug scheduling decisions to follow an evidence-based process, where the harms of the drug are assessed and reviewed so that an appropriate legal status can be assigned. Since many designer drugs sold in recent years have had little or no published research that could help inform such a decision, they have been widely sold as "legal highs", often for months, before sufficient evidence accumulates to justify placing them on the controlled drug schedules. This situation has been deemed to be undesirable, as every time a designer drug has been banned, novel compounds with similar effects have been quickly developed and brought to market, often with worse health consequences reported than the original compound. The temporary class drug status has been developed to circumvent the evidential requirements and allow drugs to be banned temporarily as soon as they are deemed by authorities to be causing harm to individuals or society. The temporary ban lasts for a period of 1 year, after which the drug would in theory be made legal again, if sufficient evidence to ban it permanently had not been forthcoming. During the period of the temporary ban, the temporary class drugs are treated equivalently to established illegal drugs, though with reduced or absent penalties for personal use amounts, and the main focus of enforcement being on importation and sale of the drugs.
prov:wasDerivedFrom
wikipedia-en:Temporary_class_drug?oldid=1080829219&ns=0
dbo:wikiPageLength
14818
foaf:isPrimaryTopicOf
wikipedia-en:Temporary_class_drug